End of course summary
Congratulations on completing this course on procalcitonin as a biomarker for antimicrobial stewardship!
On completion of this course, you should be able to:
- Demonstrate an understanding of how PCT use can benefit antimicrobial stewardship
- Summarise the use of PCT in sepsis, in ICU and outside of ICU
- Describe the use of PCT in the COVID-19 pandemic
- Discuss the benefits and controversies of PCT and assess how it should be used in your practice
We hope you enjoyed the course and found it useful for your practice.
In the comments please let us know what your main takeaway messages are and if you will be doing anything differently in your setting.
If you are interested in learning more, the BSAC FutureLearn page contains a full list of all available BSAC courses.
Membership to the British Society for Antimicrobial Chemotherapy (BSAC) is free and a great way to keep up-to-date with antimicrobial resistance and stewardship practices.
If you would like to be notified of news related to procalcitonin, you can sign up for the BRAHMS PCT newsletter. Thermofisher have provided an educational grant for this course.
Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
Reach your personal and professional goals
Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.
Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.
